FindTrial
Sign In

COMPARING OUTCOMES OF PLATELET RICH PLASMA AND HYALURONIC ACID IN MANAGING CHONDROMALACIA PATELLAE

COMPARING THE EFFICACY OF PLATELET RICH PLASMA AND HYALURONIC ACID IN MANAGING CHONDROMALACIA PATELLAE - A RANDOMISED CONTROLLED TRIAL - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112873
Enrollment
60
Registered
2026-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M224- Chondromalacia patellae

Interventions

Intervention1: PLATELET RICH PLASMA IN A CASE OF CHONDROMALACIA PATELLAE: IN CASES OF CHONDROMALACIA PATELLAE, THE PATEINT WILL BE ALLOTED RANDOMMLY. PRE-PROCEDURE VAS AND KOOS SCORES WILL BE DOCUMENT

Sponsors

AIIMS JODHPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of Chondromalacia patellae 2. Radiologically confirmed cases of chondromalacia patellae with severe disease (Outerbridge classification grade 3 and 4) 3. Non responders (Patients that have not responded to 6 weeks of conservative treatment-NSAID/analgesics)

Exclusion criteria

Exclusion criteria: 1. Known allergy to hyaluronic acid or local anaesthetic agent 2. Inflammatory joint arthritis 3. Major knee trauma or knee surgery

Design outcomes

Primary

MeasureTime frame
1. To compare the functional outcome in patients undergoing treatment of chondromalacia patellae using PRP as compared to hyaluronic acid. 2. To compare the pain relief in patients undergoing treatment of chondromalacia patellae using PRP as compared to hyaluronic acidTimepoint: Baseline, 2 weeks, 6 weeks and 3 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDR SARTHAK ALPESHKUMAR SHAH

AIIMS, JODHPUR

drsumitbanerjee@gmail.com9910895314

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026